Added to YB: 2021-10-05
Pitch date: 2021-10-05
OMER:US [bullish]
Omeros Corporation
+71.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
Market Cap
$1.0B
Pitch Price
$6.99
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.90
P/E
12.20
EV/Sales
114.43
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Omeros Corporation OMER:US
A summary for this pitch has not been created yet.
Read full article (0 min)